Braavo Capital said it has provided a further $2m of growth financing to Welltory, a California-based consumer health app used by 18 million people, extending a relationship that Braavo says dates back to 2018.
The financing will primarily support growth and recruitment for Welltory Care, its service for people living with chronic conditions. Welltory funds research and product development from its own resources.
Braavo Capital chief executive Mark Loranger said: "Welltory has been a long-term partner of Braavo, and it's incredibly rewarding to see the company continue to grow while staying true to its mission."
Welltory helps people understand their physiology and wellbeing through wearable data and heart rate variability analysis. Three months ago, Welltory launched its first Energy Lab group with 100 people with post-exertional malaise, plans to expand that group to 500, and is collecting outcomes through an IRB-approved study. Over the next year, it plans Care groups for migraine, long COVID and chronic fatigue, and irritable bowel syndrome.
Braavo has provided Welltory with several million dollars in growth financing over the course of the relationship, supporting its expansion into new products and markets. Earlier Braavo financing included a $3m credit line in September 2024 and a $2m credit facility in November 2025, the latter to support user acquisition, international expansion and the rollout of its AI Health Companion. Loranger described Welltory in November 2025 as "product-led, profitable, and scaling responsibly".
Braavo, founded in New York in 2015, describes itself as a non-dilutive financing platform for mobile app and game companies and says it has deployed more than $2bn in growth financing to over 10,000 apps.